- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Elements of Preventive Cardiology: A Guideline Topline
Click through this topline on primordial and primary CVD prevention based on the American Society of Preventive Cardiology's clinical practice statement.
A clinical practice statement from the American Society for Preventive Cardiology (ASPC) responds to widespread increases in cardiovascular (CV) risk factors in the US, including overweight and obesity, type 2 diabetes, and metabolic syndrome. Despite progress in research and clinical practice, CV disease is still a leading cause of death and disability. Part 1 of this Guideline Topline highlights the basics of primordial and primary CVD prevention. When finished, click here for part 2.
The ASPC calls for a renewed emphasis on primordial, primary and secondary prevention. Although the ASPC advocates for a subspecialty of CV medicine to help meet this challenge, it also acknowledges the need for multidisciplinary and public health efforts, and emphasizes collaboration within its definition of preventive cardiology:
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
September 2nd 2025At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.
